nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—DRD4—Gilles de la Tourette syndrome	0.286	0.342	CbGaD
Paliperidone—DRD3—Gilles de la Tourette syndrome	0.247	0.295	CbGaD
Paliperidone—DRD2—Gilles de la Tourette syndrome	0.171	0.204	CbGaD
Paliperidone—HTR2A—Gilles de la Tourette syndrome	0.132	0.158	CbGaD
Paliperidone—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00273	0.0775	CbGeAlD
Paliperidone—DRD4—brain—Gilles de la Tourette syndrome	0.00135	0.0382	CbGeAlD
Paliperidone—Risperidone—DRD4—Gilles de la Tourette syndrome	0.00131	0.177	CrCbGaD
Paliperidone—DRD3—nervous system—Gilles de la Tourette syndrome	0.00124	0.0351	CbGeAlD
Paliperidone—Iloperidone—DRD4—Gilles de la Tourette syndrome	0.00123	0.166	CrCbGaD
Paliperidone—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00119	0.0338	CbGeAlD
Paliperidone—Risperidone—DRD3—Gilles de la Tourette syndrome	0.00113	0.152	CrCbGaD
Paliperidone—DRD1—midbrain—Gilles de la Tourette syndrome	0.00108	0.0306	CbGeAlD
Paliperidone—Iloperidone—DRD3—Gilles de la Tourette syndrome	0.00106	0.143	CrCbGaD
Paliperidone—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000951	0.027	CbGeAlD
Paliperidone—DRD3—brain—Gilles de la Tourette syndrome	0.000947	0.0269	CbGeAlD
Paliperidone—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000916	0.026	CbGeAlD
Paliperidone—DRD1—nervous system—Gilles de la Tourette syndrome	0.000887	0.0252	CbGeAlD
Paliperidone—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000874	0.0248	CbGeAlD
Paliperidone—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000854	0.0242	CbGeAlD
Paliperidone—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000846	0.024	CbGeAlD
Paliperidone—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000838	0.0238	CbGeAlD
Paliperidone—Risperidone—DRD2—Gilles de la Tourette syndrome	0.00078	0.105	CrCbGaD
Paliperidone—Iloperidone—DRD2—Gilles de la Tourette syndrome	0.000732	0.0989	CrCbGaD
Paliperidone—ADRA1B—brain—Gilles de la Tourette syndrome	0.000727	0.0206	CbGeAlD
Paliperidone—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000718	0.0204	CbGeAlD
Paliperidone—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000705	0.02	CbGeAlD
Paliperidone—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000696	0.0197	CbGeAlD
Paliperidone—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000692	0.0196	CbGeAlD
Paliperidone—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000689	0.0196	CbGeAlD
Paliperidone—DRD1—brain—Gilles de la Tourette syndrome	0.000678	0.0192	CbGeAlD
Paliperidone—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00067	0.019	CbGeAlD
Paliperidone—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000663	0.0188	CbGeAlD
Paliperidone—DRD2—midbrain—Gilles de la Tourette syndrome	0.000637	0.0181	CbGeAlD
Paliperidone—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000619	0.0176	CbGeAlD
Paliperidone—Risperidone—HTR2A—Gilles de la Tourette syndrome	0.000603	0.0815	CrCbGaD
Paliperidone—HTR1A—nervous system—Gilles de la Tourette syndrome	0.00058	0.0165	CbGeAlD
Paliperidone—Iloperidone—HTR2A—Gilles de la Tourette syndrome	0.000566	0.0764	CrCbGaD
Paliperidone—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000558	0.0158	CbGeAlD
Paliperidone—HTR1B—brain—Gilles de la Tourette syndrome	0.000549	0.0156	CbGeAlD
Paliperidone—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000534	0.0152	CbGeAlD
Paliperidone—HTR1D—brain—Gilles de la Tourette syndrome	0.000532	0.0151	CbGeAlD
Paliperidone—HTR2C—brain—Gilles de la Tourette syndrome	0.000527	0.0149	CbGeAlD
Paliperidone—DRD2—nervous system—Gilles de la Tourette syndrome	0.000524	0.0149	CbGeAlD
Paliperidone—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000515	0.0146	CbGeAlD
Paliperidone—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000509	0.0145	CbGeAlD
Paliperidone—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000504	0.0143	CbGeAlD
Paliperidone—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000494	0.014	CbGeAlD
Paliperidone—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00049	0.0139	CbGeAlD
Paliperidone—HTR1A—brain—Gilles de la Tourette syndrome	0.000443	0.0126	CbGeAlD
Paliperidone—HTR2A—midbrain—Gilles de la Tourette syndrome	0.00042	0.0119	CbGeAlD
Paliperidone—HRH1—nervous system—Gilles de la Tourette syndrome	0.000414	0.0117	CbGeAlD
Paliperidone—ADRA1A—brain—Gilles de la Tourette syndrome	0.000409	0.0116	CbGeAlD
Paliperidone—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000406	0.0115	CbGeAlD
Paliperidone—DRD2—brain—Gilles de la Tourette syndrome	0.0004	0.0114	CbGeAlD
Paliperidone—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000398	0.0113	CbGeAlD
Paliperidone—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000391	0.0111	CbGeAlD
Paliperidone—ADRA2C—brain—Gilles de la Tourette syndrome	0.000389	0.011	CbGeAlD
Paliperidone—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000346	0.00981	CbGeAlD
Paliperidone—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000333	0.00944	CbGeAlD
Paliperidone—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00032	0.00908	CbGeAlD
Paliperidone—HRH1—brain—Gilles de la Tourette syndrome	0.000316	0.00898	CbGeAlD
Paliperidone—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000315	0.00893	CbGeAlD
Paliperidone—ADRA2A—brain—Gilles de la Tourette syndrome	0.000311	0.00882	CbGeAlD
Paliperidone—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000308	0.00874	CbGeAlD
Paliperidone—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000303	0.0086	CbGeAlD
Paliperidone—HTR2A—brain—Gilles de la Tourette syndrome	0.000264	0.0075	CbGeAlD
Paliperidone—CYP2D6—brain—Gilles de la Tourette syndrome	0.000241	0.00683	CbGeAlD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.46e-05	0.000615	CbGpPWpGaD
Paliperidone—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.43e-05	0.000613	CbGpPWpGaD
Paliperidone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.4e-05	0.000611	CbGpPWpGaD
Paliperidone—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	7.35e-05	0.000606	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.27e-05	0.0006	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.17e-05	0.000592	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.16e-05	0.000591	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.14e-05	0.000589	CbGpPWpGaD
Paliperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.09e-05	0.000586	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.08e-05	0.000584	CbGpPWpGaD
Paliperidone—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.95e-05	0.000574	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.95e-05	0.000574	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.95e-05	0.000573	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.93e-05	0.000572	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.91e-05	0.000571	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.88e-05	0.000568	CbGpPWpGaD
Paliperidone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.71e-05	0.000554	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.71e-05	0.000554	CbGpPWpGaD
Paliperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.69e-05	0.000553	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.69e-05	0.000552	CbGpPWpGaD
Paliperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.69e-05	0.000552	CbGpPWpGaD
Paliperidone—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.68e-05	0.000551	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.68e-05	0.000551	CbGpPWpGaD
Paliperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.6e-05	0.000545	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.58e-05	0.000544	CbGpPWpGaD
Paliperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.57e-05	0.000542	CbGpPWpGaD
Paliperidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.5e-05	0.000536	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.49e-05	0.000536	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.48e-05	0.000535	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.45e-05	0.000533	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	6.41e-05	0.00053	CbGpPWpGaD
Paliperidone—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.39e-05	0.000528	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.39e-05	0.000528	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.25e-05	0.000516	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.22e-05	0.000514	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.07e-05	0.000501	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.05e-05	0.000499	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.97e-05	0.000493	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.96e-05	0.000492	CbGpPWpGaD
Paliperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.96e-05	0.000492	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.95e-05	0.000492	CbGpPWpGaD
Paliperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.89e-05	0.000486	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.89e-05	0.000486	CbGpPWpGaD
Paliperidone—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.87e-05	0.000485	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.85e-05	0.000483	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.8e-05	0.000479	CbGpPWpGaD
Paliperidone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.79e-05	0.000478	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.79e-05	0.000478	CbGpPWpGaD
Paliperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.75e-05	0.000475	CbGpPWpGaD
Paliperidone—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.75e-05	0.000475	CbGpPWpGaD
Paliperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.72e-05	0.000472	CbGpPWpGaD
Paliperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.68e-05	0.000469	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.68e-05	0.000469	CbGpPWpGaD
Paliperidone—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.66e-05	0.000467	CbGpPWpGaD
Paliperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.56e-05	0.000459	CbGpPWpGaD
Paliperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.48e-05	0.000452	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.43e-05	0.000449	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.4e-05	0.000446	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.39e-05	0.000445	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.29e-05	0.000437	CbGpPWpGaD
Paliperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.28e-05	0.000436	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.28e-05	0.000435	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.24e-05	0.000432	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	5.21e-05	0.00043	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.13e-05	0.000423	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.09e-05	0.00042	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.09e-05	0.00042	CbGpPWpGaD
Paliperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.05e-05	0.000417	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.05e-05	0.000417	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000415	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.98e-05	0.000411	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.96e-05	0.000409	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.91e-05	0.000406	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.86e-05	0.000402	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	4.77e-05	0.000394	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.76e-05	0.000393	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.74e-05	0.000391	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.66e-05	0.000384	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.64e-05	0.000383	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.62e-05	0.000381	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.58e-05	0.000378	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.56e-05	0.000377	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.54e-05	0.000375	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.54e-05	0.000374	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.52e-05	0.000373	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.52e-05	0.000373	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.41e-05	0.000364	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.38e-05	0.000362	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.36e-05	0.00036	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.35e-05	0.000359	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.3e-05	0.000355	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.24e-05	0.00035	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.21e-05	0.000348	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.17e-05	0.000344	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.15e-05	0.000342	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.13e-05	0.000341	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.11e-05	0.000339	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.05e-05	0.000335	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.05e-05	0.000334	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.01e-05	0.000331	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.95e-05	0.000326	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.93e-05	0.000324	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.91e-05	0.000323	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.89e-05	0.000321	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000317	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.79e-05	0.000313	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.78e-05	0.000312	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.78e-05	0.000312	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.77e-05	0.000312	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.73e-05	0.000308	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.72e-05	0.000307	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.7e-05	0.000306	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.68e-05	0.000304	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.68e-05	0.000303	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.67e-05	0.000303	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.66e-05	0.000302	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.61e-05	0.000298	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000295	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.55e-05	0.000293	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.53e-05	0.000292	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.53e-05	0.000291	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.52e-05	0.00029	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.44e-05	0.000284	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.44e-05	0.000284	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.43e-05	0.000283	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.43e-05	0.000283	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.43e-05	0.000283	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.42e-05	0.000282	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.4e-05	0.00028	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.38e-05	0.000279	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.38e-05	0.000279	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.37e-05	0.000278	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.37e-05	0.000278	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.33e-05	0.000275	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.33e-05	0.000275	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.32e-05	0.000274	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.32e-05	0.000274	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.31e-05	0.000273	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.28e-05	0.000271	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.28e-05	0.000271	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.27e-05	0.00027	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.25e-05	0.000268	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000265	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.21e-05	0.000265	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.2e-05	0.000264	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.19e-05	0.000264	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000257	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.1e-05	0.000256	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.07e-05	0.000254	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.07e-05	0.000253	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.06e-05	0.000252	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.06e-05	0.000252	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.05e-05	0.000252	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.05e-05	0.000251	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.02e-05	0.00025	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000249	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3e-05	0.000248	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.99e-05	0.000247	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.98e-05	0.000246	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.98e-05	0.000246	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.97e-05	0.000245	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000244	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.91e-05	0.000241	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.00024	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.88e-05	0.000238	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.84e-05	0.000234	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.81e-05	0.000232	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.00023	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.78e-05	0.000229	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.77e-05	0.000229	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.77e-05	0.000228	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.75e-05	0.000227	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.73e-05	0.000225	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.71e-05	0.000224	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.71e-05	0.000224	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000223	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.67e-05	0.00022	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.61e-05	0.000216	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000213	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.56e-05	0.000212	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.54e-05	0.00021	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.52e-05	0.000208	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.49e-05	0.000205	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.47e-05	0.000204	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.46e-05	0.000203	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.45e-05	0.000202	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.44e-05	0.000201	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.39e-05	0.000198	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.37e-05	0.000195	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.36e-05	0.000195	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.33e-05	0.000193	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000192	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000186	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000185	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.22e-05	0.000183	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.2e-05	0.000182	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.17e-05	0.00018	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.00018	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000179	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.17e-05	0.000179	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.14e-05	0.000177	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.13e-05	0.000176	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.11e-05	0.000174	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.1e-05	0.000173	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.09e-05	0.000173	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.03e-05	0.000168	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000167	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.000167	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2e-05	0.000165	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.97e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.96e-05	0.000162	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.95e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.94e-05	0.00016	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.94e-05	0.00016	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.9e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.000156	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.000156	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000152	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.83e-05	0.000151	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.81e-05	0.000149	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.81e-05	0.000149	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.81e-05	0.000149	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000147	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.78e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.77e-05	0.000146	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000146	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.76e-05	0.000145	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.75e-05	0.000145	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000144	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000142	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.71e-05	0.000142	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.65e-05	0.000136	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.64e-05	0.000135	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.63e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.6e-05	0.000132	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.54e-05	0.000127	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.52e-05	0.000126	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.49e-05	0.000123	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.38e-05	0.000114	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.33e-05	0.00011	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.32e-05	0.000109	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.28e-05	0.000106	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.26e-05	0.000104	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.17e-05	9.62e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.14e-05	9.45e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.12e-05	9.27e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.04e-05	8.61e-05	CbGpPWpGaD
